Unknown

Dataset Information

0

Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.


ABSTRACT:

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 (COVID-19), but it is not clear whether this RNAemia reflects viremia (ie, virus particles) and how it relates to host immune responses and outcomes.

Methods

SARS-CoV-2 vRNA was quantified in plasma samples from observational cohorts of 51 COVID-19 patients including 9 outpatients, 19 hospitalized (non-intensive care unit [ICU]), and 23 ICU patients. vRNA levels were compared with cross-sectional indices of COVID-19 severity and prospective clinical outcomes. We used multiple imaging methods to visualize virions in plasma.

Results

SARS-CoV-2 vRNA was detected in plasma of 100%, 52.6%, and 11.1% of ICU, non-ICU, and outpatients, respectively. Virions were detected in plasma pellets using electron tomography and immunostaining. Plasma vRNA levels were significantly higher in ICU > non-ICU > outpatients (P < .0001); for inpatients, plasma vRNA levels were strongly associated with higher World Health Organization (WHO) score at admission (P = .01), maximum WHO score (P = .002), and discharge disposition (P = .004). A plasma vRNA level >6000 copies/mL was strongly associated with mortality (hazard ratio, 10.7). Levels of vRNA were significantly associated with several inflammatory biomarkers (P < .01) but not with plasma neutralizing antibody titers (P = .8).

Conclusions

Visualization of virus particles in plasma indicates that SARS-CoV-2 RNAemia is due, at least in part, to viremia. The levels of SARS-CoV-2 RNAemia correlate strongly with disease severity, patient outcome, and specific inflammatory biomarkers but not with neutralizing antibody titers.

SUBMITTER: Jacobs JL 

PROVIDER: S-EPMC9070832 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.

Jacobs Jana L JL   Bain William W   Naqvi Asma A   Staines Brittany B   Castanha Priscila M S PMS   Yang Haopu H   Boltz Valerie F VF   Barratt-Boyes Simon S   Marques Ernesto T A ETA   Mitchell Stephanie L SL   Methé Barbara B   Olonisakin Tolani F TF   Haidar Ghady G   Burke Thomas W TW   Petzold Elizabeth E   Denny Thomas T   Woods Chris W CW   McVerry Bryan J BJ   Lee Janet S JS   Watkins Simon C SC   St Croix Claudette M CM   Morris Alison A   Kearney Mary F MF   Ladinsky Mark S MS   Bjorkman Pamela J PJ   Kitsios Georgios D GD   Mellors John W JW  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20220501 9


<h4>Background</h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 (COVID-19), but it is not clear whether this RNAemia reflects viremia (ie, virus particles) and how it relates to host immune responses and outcomes.<h4>Methods</h4>SARS-CoV-2 vRNA was quantified in plasma samples from observational cohorts of 51 COVID-19 patients including 9 outpatients, 19 hospitalized (non-intensive care  ...[more]

Similar Datasets

| S-EPMC8763956 | biostudies-literature
| S-EPMC7138902 | biostudies-literature
| S-EPMC9384672 | biostudies-literature
| S-EPMC10169416 | biostudies-literature
| S-EPMC7890673 | biostudies-literature
| S-EPMC8017544 | biostudies-literature
| S-EPMC8522400 | biostudies-literature
| S-EPMC3035556 | biostudies-literature
| S-EPMC8083268 | biostudies-literature